Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MODAFINIL 200 MG TABLET

modafinil
$0.3507per EA
DEA Schedule CIV

Strength

200 mg/1

Manufacturer

Major Pharmaceuticals

NDC

00904679204

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MODAFINIL

Approval Type

Generic (ANDA)

FDA Application

ANDA077667

On Market Since

2/3/2014

Pharmacological Classes

Central Nervous System Stimulation
Increased Sympathetic Activity
Sympathomimetic-like Agent

Price History

1W

0.0%

1M

-0.5%

3M

-9.4%

6M

-9.9%

1Y

-7.4%

3Y

-27.7%

5Y

-51.8%

All

-55.4%

Generic Alternatives

1 alternative • Same active ingredient

MODAFINIL 200 MG TABLET
Generic
60505252701•Apotex Corp.
$0.3507

Related Drugs

Same classification

BACK-BODY PAIN 500-32.5 MG CPLT
Generic
70000012702•Cardinal Health
$0.0448
per EA
TENSION HEADACHE CAPLET
Generic
70000015901•Cardinal Health
$0.0579
per EA
TENSION HEADACHE CAPLET
Generic
70000015902•Cardinal Health
$0.0579
per EA
EXTRA PAIN RELIEF CAPLET
Generic
49483037000•Time-Cap Labs Inc.
$0.0621
per EA
NASAL SPRAY 0.05%
Generic
36800030410•Topco Associates LLC
$0.0625
per ML
NASAL SPRAY 0.05%
Generic
36800081710•Topco Associates LLC
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203005•Taro Pharmaceuticals U.S.A. Inc.
$0.0625
per ML
QC HEADACHE RELIEF TABLET
Generic
63868048501•Chain Drug Marketing Association
$0.0629
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037462•L. Perrigo Company
$0.0668
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037478•L. Perrigo Company
$0.0668
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy